{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T18:49:17Z","timestamp":1771872557376,"version":"3.50.1"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,6,7]],"date-time":"2011-06-07T00:00:00Z","timestamp":1307404800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s12031-011-9558-7","type":"journal-article","created":{"date-parts":[[2011,6,6]],"date-time":"2011-06-06T15:18:35Z","timestamp":1307373515000},"page":"713-723","source":"Crossref","is-referenced-by-count":16,"title":["Medical Management of Frontotemporal Dementias: The Importance of the Caregiver in Symptom Assessment and Guidance of Treatment Strategies"],"prefix":"10.1007","volume":"45","author":[{"given":"Gregory A.","family":"Jicha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,6,7]]},"reference":[{"key":"9558_CR1","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/gps.894","volume":"18","author":"G Adler","year":"2003","unstructured":"Adler G, Teufel M, Drach LM (2003) Pharmacological treatment of frontotemporal dementia: treatment response to the MAO-A inhibitor moclobemide. Int J Geriatr Psychiatry 18:653\u2013655","journal-title":"Int J Geriatr Psychiatry"},{"key":"9558_CR2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/hup.472","volume":"18","author":"H Allain","year":"2003","unstructured":"Allain H, Bentue-Ferrer D, Tribut O, Merienne M, Belliard S (2003) Drug therapy of frontotemporal dementia. Hum Psychopharmacol 18:221\u2013225","journal-title":"Hum Psychopharmacol"},{"key":"9558_CR3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/NRL.0b013e3181b1d5c6","volume":"16","author":"Z Arvanitakis","year":"2010","unstructured":"Arvanitakis Z (2010) Update on frontotemporal dementia. Neurologist 16:16\u201322","journal-title":"Neurologist"},{"key":"9558_CR4","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/WCO.0b013e32833c7ac2","volume":"23","author":"RS Bedlack","year":"2010","unstructured":"Bedlack RS (2010) Amyotrophic lateral sclerosis: current practice and future treatments. Curr Opin Neurol 23:524\u2013529","journal-title":"Curr Opin Neurol"},{"key":"9558_CR5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1177\/1533317509356692","volume":"25","author":"H Bei","year":"2010","unstructured":"Bei H, Ross L, Neuhaus J, Knopman D, Kramer J, Boeve B, Caselli RJ, Graff-Radford N, Mendez MF, Miller BL, Boxer AL (2010) Off-label medication use in frontotemporal dementia. Am J Alzheimers Dis Other Demen 25:128\u2013133","journal-title":"Am J Alzheimers Dis Other Demen"},{"issue":"1","key":"9558_CR6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1755-5949.2009.00116.x","volume":"17","author":"MC Bellingham","year":"2011","unstructured":"Bellingham MC (2011) A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade? CNS Neurosci Ther 17(1):4\u201331","journal-title":"CNS Neurosci Ther"},{"key":"9558_CR7","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00213-007-0992-8","volume":"196","author":"DM Bowen","year":"2008","unstructured":"Bowen DM, Procter AW, Mann DM, Snowden JS, Esiri MM, Neary D, Francis PT (2008) Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapy. Psychopharmacology (Berl) 196:603\u2013610","journal-title":"Psychopharmacology (Berl)"},{"key":"9558_CR8","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1097\/WAD.0b013e31815c345e","volume":"21","author":"AL Boxer","year":"2007","unstructured":"Boxer AL, Boeve BF (2007) Frontotemporal dementia treatment: current symptomatic therapies and implications of recent genetic, biochemical, and neuroimaging studies. Alzheimer Dis Assoc Disord 21:S79\u2013S87","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"9558_CR9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/WAD.0b013e318197852f","volume":"23","author":"AL Boxer","year":"2009","unstructured":"Boxer AL, Lipton AM, Womack K, Merrilees J, Neuhaus J, Pavlic D, Gandhi A, Red D, Martin-Cook K, Svetlik D, Miller BL (2009) An open-label study of memantine treatment in 3 subtypes of frontotemporal lobar degeneration. Alzheimer Dis Assoc Disord 23:211\u2013217","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"9558_CR10","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1212\/01.WNL.0000142042.50528.2F","volume":"63","author":"BR Brooks","year":"2004","unstructured":"Brooks BR, Thisted RA, Appel SH, Bradley WG, Olney RK, Berg JE, Pope LE, Smith RA (2004) Treatment of pseudobulbar affect in ALS with dextromethorphan\/quinidine: a randomized trial. Neurology 63:1364\u20131370","journal-title":"Neurology"},{"key":"9558_CR11","doi-asserted-by":"crossref","first-page":"1942\u20131199","DOI":"10.2174\/092986710791163939","volume":"17","author":"BC Cheah","year":"2010","unstructured":"Cheah BC, Vucic S, Krishnan AV, Kiernan MC (2010) Riluzole, neuroprotection and amyotrophic lateral sclerosis. Curr Med Chem 17:1942\u20131199","journal-title":"Curr Med Chem"},{"key":"9558_CR12","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s11920-005-0040-5","volume":"7","author":"TW Chow","year":"2005","unstructured":"Chow TW (2005) Treatment approaches to symptoms associated with frontotemporal degeneration. Curr Psychiatry Rep 7:376\u2013380","journal-title":"Curr Psychiatry Rep"},{"key":"9558_CR13","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1001\/archneurol.2009.92","volume":"66","author":"TW Chow","year":"2009","unstructured":"Chow TW, Binns MA, Cummings JL, Lam I, Black SE, Miller BL, Freedman M, Stuss DT, van Reekum R (2009) Apathy symptom profile and behavioral associations in frontotemporal dementia vs dementia of Alzheimer type. Arch Neurol 66:888\u2013893","journal-title":"Arch Neurol"},{"key":"9558_CR14","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/WNN.0b013e31816bdf73","volume":"21","author":"M Cruz","year":"2008","unstructured":"Cruz M, Marinho V, Fontenelle LF, Engelhardt E, Laks J (2008) Topiramate may modulate alcohol abuse but not other compulsive behaviors in frontotemporal dementia: case report. Cogn Behav Neurol 21:104\u2013106","journal-title":"Cogn Behav Neurol"},{"key":"9558_CR15","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00004714-200006000-00018","volume":"20","author":"RC Curtis","year":"2000","unstructured":"Curtis RC, Resch DS (2000) Case of pick's central lobar atrophy with apparent stabilization of cognitive decline after treatment with risperidone. J Clin Psychopharmacol 20:384\u2013385","journal-title":"J Clin Psychopharmacol"},{"key":"9558_CR16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1468-1331.2007.02032.x","volume":"15","author":"K Czarnecki","year":"2008","unstructured":"Czarnecki K, Kumar N, Josephs KA (2008) Parkinsonism and tardive antecollis in frontotemporal dementia\u2014increased sensitivity to newer antipsychotics? Eur J Neurol 15:199\u2013201","journal-title":"Eur J Neurol"},{"key":"9558_CR17","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s00213-003-1686-5","volume":"172","author":"JB Deakin","year":"2004","unstructured":"Deakin JB, Rahman S, Nestor PJ, Hodges JR, Sahakian BJ (2004) Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial. Psychopharmacology (Berl) 172:400\u2013408","journal-title":"Psychopharmacology (Berl)"},{"key":"9558_CR18","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/gps.1973","volume":"23","author":"J Diehl-Schmid","year":"2008","unstructured":"Diehl-Schmid J, Forstl H, Perneczky R, Pohl C, Kurz A (2008) A 6-month, open-label study of memantine in patients with frontotemporal dementia. Int J Geriatr Psychiatry 23:754\u2013759","journal-title":"Int J Geriatr Psychiatry"},{"key":"9558_CR19","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1001\/archinternmed.2009.456","volume":"170","author":"ER Dorsey","year":"2010","unstructured":"Dorsey ER, Rabbani A, Gallagher SA, Conti RM, Alexander GC (2010) Impact of FDA black box advisory on antipsychotic medication use. Arch Intern Med 170:96\u2013103","journal-title":"Arch Intern Med"},{"key":"9558_CR20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/15622970601016538","volume":"8","author":"A Fellgiebel","year":"2007","unstructured":"Fellgiebel A, Muller MJ, Hiemke C, Bartenstein P, Schreckenberger M (2007) Clinical improvement in a case of frontotemporal dementia under aripiprazole treatment corresponds to partial recovery of disturbed frontal glucose metabolism. World J Biol Psychiatry 8:123\u2013126","journal-title":"World J Biol Psychiatry"},{"issue":"Suppl 1","key":"9558_CR21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000051214","volume":"10","author":"I Ferrer","year":"1999","unstructured":"Ferrer I (1999) Neurons and their dendrites in frontotemporal dementia. Dement Geriatr Cogn Disord 10(Suppl 1):55\u201360","journal-title":"Dement Geriatr Cogn Disord"},{"key":"9558_CR22","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/ana.20365","volume":"57","author":"M Franceschi","year":"2005","unstructured":"Franceschi M, Anchisi D, Pelati O, Zuffi M, Matarrese M, Moresco RM, Fazio F, Perani D (2005) Glucose metabolism and serotonin receptors in the frontotemporal lobe degeneration. Ann Neurol 57:216\u2013225","journal-title":"Ann Neurol"},{"issue":"Suppl 1","key":"9558_CR23","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1017\/S0317167100005680","volume":"34","author":"M Freedman","year":"2007","unstructured":"Freedman M (2007) Frontotemporal dementia: recommendations for therapeutic studies, designs, and approaches. Can J Neurol Sci 34(Suppl 1):S118\u2013S124","journal-title":"Can J Neurol Sci"},{"key":"9558_CR24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1600-0404.1994.tb01661.x","volume":"89","author":"GB Frisoni","year":"1994","unstructured":"Frisoni GB, Pizzolato G, Bianchetti A, Chierichetti F, Ferlin G, Battistin L, Trabucchi M (1994) Single photon emission computed tomography with [99Tc]-HM-PAO and [123I]-IBZM in Alzheimer's disease and dementia of frontal type: preliminary results. Acta Neurol Scand 89:199\u2013203","journal-title":"Acta Neurol Scand"},{"key":"9558_CR25","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000080989","volume":"1","author":"S Froelich-Fabre","year":"2004","unstructured":"Froelich-Fabre S, Skoglund L, Ostojic J, Kilander L, Lindau M, Glaser A, Basun H, Lannfelt L (2004) Clinical and molecular aspects of frontotemporal dementia. Neurodegener Dis 1:218\u2013224","journal-title":"Neurodegener Dis"},{"key":"9558_CR26","first-page":"292","volume":"58","author":"V Galariotis","year":"2005","unstructured":"Galariotis V, Bodi N, Janka Z, Kalman J (2005a) Frontotemporal dementia\u2014part III. Clinical diagnosis and treatment. Ideggy\u00f3gy Sz 58:292\u2013297","journal-title":"Ideggy\u00f3gy Sz"},{"key":"9558_CR27","first-page":"220","volume":"58","author":"V Galariotis","year":"2005","unstructured":"Galariotis V, Bodi N, Janka Z, Kalman J (2005b) Frontotemporal dementia\u2014part II. Differential diagnosis, genetics, molecular pathomechanism and pathology. Ideggy\u00f3gy Sz 58:220\u2013224","journal-title":"Ideggy\u00f3gy Sz"},{"key":"9558_CR28","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1136\/jnnp.74.7.867","volume":"74","author":"TB Gislason","year":"2003","unstructured":"Gislason TB, Sjogren M, Larsson L, Skoog I (2003) The prevalence of frontal variant frontotemporal dementia and the frontal lobe syndrome in a population based sample of 85\u00a0year olds. J Neurol Neurosurg Psychiatry 74:867\u2013871","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9558_CR29","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/155005940403500212","volume":"35","author":"HW Goforth","year":"2004","unstructured":"Goforth HW, Konopka L, Primeau M, Ruth A, O'Donnell K, Patel R, Poprawski T, Shirazi P, Rao M (2004) Quantitative electroencephalography in frontotemporal dementia with methylphenidate response: a case study. Clin EEG Neurosci 35:108\u2013111","journal-title":"Clin EEG Neurosci"},{"issue":"8","key":"9558_CR30","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2174\/156720510793611628","volume":"7","author":"I Gozes","year":"2010","unstructured":"Gozes I (2010) Tau pathology and future therapeutics. Curr Alzheimer Res 7(8):685\u2013696","journal-title":"Curr Alzheimer Res"},{"key":"9558_CR31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1055\/s-2006-956755","volume":"27","author":"NR Graff-Radford","year":"2007","unstructured":"Graff-Radford NR, Woodruff BK (2007) Frontotemporal dementia. Semin Neurol 27:48\u201357","journal-title":"Semin Neurol"},{"key":"9558_CR32","first-page":"507","volume":"131","author":"LA Hansen","year":"1988","unstructured":"Hansen LA, Deteresa R, Tobias H, Alford M, Terry RD (1988) Neocortical morphometry and cholinergic neurochemistry in Pick's disease. Am J Pathol 131:507\u2013518","journal-title":"Am J Pathol"},{"key":"9558_CR33","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/sj.npp.1301492","volume":"33","author":"DV Jeste","year":"2008","unstructured":"Jeste DV, Blazer D, Casey D, Meeks T, Salzman C, Schneider L, Tariot P, Yaffe K (2008) ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia. Neuropsychopharmacology 33:957\u2013970","journal-title":"Neuropsychopharmacology"},{"key":"9558_CR34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0022-510X(88)90020-2","volume":"83","author":"I Kanazawa","year":"1988","unstructured":"Kanazawa I, Kwak S, Sasaki H, Muramoto O, Mizutani T, Hori A, Nukina N (1988) Studies on neurotransmitter markers of the basal ganglia in Pick's disease, with special reference to dopamine reduction. J Neurol Sci 83:63\u201374","journal-title":"J Neurol Sci"},{"key":"9558_CR35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1176\/appi.neuropsych.22.1.19","volume":"22","author":"ED Kaye","year":"2010","unstructured":"Kaye ED, Petrovic-Poljak A, Verhoeff NP, Freedman M (2010) Frontotemporal dementia and pharmacologic interventions. J Neuropsychiatry Clin Neurosci 22:19\u201329","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"9558_CR36","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/01.nrl.0000094943.84390.cf","volume":"9","author":"A Kertesz","year":"2003","unstructured":"Kertesz A (2003) Pick Complex: an integrative approach to frontotemporal dementia: primary progressive aphasia, corticobasal degeneration, and progressive supranuclear palsy. Neurologist 9:311\u2013317","journal-title":"Neurologist"},{"key":"9558_CR37","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000077155","volume":"17","author":"A Kertesz","year":"2004","unstructured":"Kertesz A, Munoz D (2004) Relationship between frontotemporal dementia and corticobasal degeneration\/progressive supranuclear palsy. Dement Geriatr Cogn Disord 17:282\u2013286","journal-title":"Dement Geriatr Cogn Disord"},{"key":"9558_CR38","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1017\/S1355617700644041","volume":"6","author":"A Kertesz","year":"2000","unstructured":"Kertesz A, Nadkarni N, Davidson W, Thomas AW (2000) The Frontal Behavioral Inventory in the differential diagnosis of frontotemporal dementia. J Int Neuropsychol Soc 6:460\u2013468","journal-title":"J Int Neuropsychol Soc"},{"key":"9558_CR39","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000113034","volume":"25","author":"A Kertesz","year":"2008","unstructured":"Kertesz A, Morlog D, Light M, Blair M, Davidson W, Jesso S, Brashear R (2008) Galantamine in frontotemporal dementia and primary progressive aphasia. Dement Geriatr Cogn Disord 25:178\u2013185","journal-title":"Dement Geriatr Cogn Disord"},{"key":"9558_CR40","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1212\/01.wnl.0000313366.76973.8a","volume":"70","author":"CM Kipps","year":"2008","unstructured":"Kipps CM, Nestor PJ, Dawson CE, Mitchell J, Hodges JR (2008) Measuring progression in frontotemporal dementia: implications for therapeutic interventions. Neurology 70:2046\u20132052","journal-title":"Neurology"},{"key":"9558_CR41","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s11910-008-0075-1","volume":"8","author":"HS Kirshner","year":"2008","unstructured":"Kirshner HS (2008) Controversies in behavioral neurology: the use of atypical antipsychotic drugs to treat neurobehavioral symptoms in dementia. Curr Neurol Neurosci Rep 8:471\u2013474","journal-title":"Curr Neurol Neurosci Rep"},{"key":"9558_CR42","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000077171","volume":"17","author":"F Lebert","year":"2004","unstructured":"Lebert F, Stekke W, Hasenbroekx C, Pasquier F (2004) Frontotemporal dementia: a randomised, controlled trial with trazodone. Dement Geriatr Cogn Disord 17:355\u2013359","journal-title":"Dement Geriatr Cogn Disord"},{"key":"9558_CR43","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.jocn.2009.03.005","volume":"16","author":"P Lillo","year":"2009","unstructured":"Lillo P, Hodges JR (2009) Frontotemporal dementia and motor neurone disease: overlapping clinic-pathological disorders. J Clin Neurosci 16:1131\u20131135","journal-title":"J Clin Neurosci"},{"key":"9558_CR44","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000067973","volume":"15","author":"M Lindau","year":"2003","unstructured":"Lindau M, Jelic V, Johansson SE, Andersen C, Wahlund LO, Almkvist O (2003) Quantitative EEG abnormalities and cognitive dysfunctions in frontotemporal dementia and Alzheimer's disease. Dement Geriatr Cogn Disord 15:106\u2013114","journal-title":"Dement Geriatr Cogn Disord"},{"key":"9558_CR45","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2478\/10004-1254-60-2009-1921","volume":"60","author":"RM Liscic","year":"2009","unstructured":"Liscic RM (2009) Frontotemporal dementias: update on recent developments in molecular genetics and neuropathology. Arh Hig Rada Toksikol 60:117\u2013122","journal-title":"Arh Hig Rada Toksikol"},{"key":"9558_CR46","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1212\/01.wnl.0000434309.85312.19","volume":"55","author":"PS Mathuranath","year":"2000","unstructured":"Mathuranath PS, Nestor PJ, Berrios GE, Rakowicz W, Hodges JR (2000a) A brief cognitive test battery to differentiate Alzheimer's disease and frontotemporal dementia. Neurology 55:1613\u20131620","journal-title":"Neurology"},{"key":"9558_CR47","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1136\/jnnp.68.3.304","volume":"68","author":"PS Mathuranath","year":"2000","unstructured":"Mathuranath PS, Xuereb JH, Bak T, Hodges JR (2000b) Corticobasal ganglionic degeneration and\/or frontotemporal dementia? A report of two overlap cases and review of literature. J Neurol Neurosurg Psychiatry 68:304\u2013312","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9558_CR48","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000197896","volume":"24","author":"MF Mendez","year":"2009","unstructured":"Mendez MF (2009) Frontotemporal dementia: therapeutic interventions. Front Neurol Neurosci 24:168\u2013178","journal-title":"Front Neurol Neurosci"},{"key":"9558_CR49","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/01.JGP.0000231744.69631.33","volume":"15","author":"MF Mendez","year":"2007","unstructured":"Mendez MF, Shapira JS, McMurtray A, Licht E (2007) Preliminary findings: behavioral worsening on donepezil in patients with frontotemporal dementia. Am J Geriatr Psychiatry 15:84\u201387","journal-title":"Am J Geriatr Psychiatry"},{"key":"9558_CR50","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3109\/17482961003605788","volume":"11","author":"J Merrilees","year":"2010","unstructured":"Merrilees J, Klapper J, Murphy J, Lomen-Hoerth C, Miller BL (2010) Cognitive and behavioral challenges in caring for patients with frontotemporal dementia and amyotrophic lateral sclerosis. Amyotroph Lateral Scler 11:298\u2013302","journal-title":"Amyotroph Lateral Scler"},{"key":"9558_CR51","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jns.2005.09.018","volume":"245","author":"A Miller","year":"2006","unstructured":"Miller A (2006) Pseudobulbar affect in multiple sclerosis: toward the development of innovative therapeutic strategies. J Neurol Sci 245:153\u2013159","journal-title":"J Neurol Sci"},{"key":"9558_CR52","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1212\/WNL.0b013e3181bc0141","volume":"73","author":"RG Miller","year":"2009","unstructured":"Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, Kalra S, Katz JS, Mitsumoto H, Rosenfeld J, Shoesmith C, Strong MJ, Woolley SC (2009) Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 73:1218\u20131226","journal-title":"Neurology"},{"key":"9558_CR53","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1212\/01.wnl.0000264897.13722.53","volume":"68","author":"E Mioshi","year":"2007","unstructured":"Mioshi E, Kipps CM, Dawson K, Mitchell J, Graham A, Hodges JR (2007) Activities of daily living in frontotemporal dementia and Alzheimer disease. Neurology 68:2077\u20132084","journal-title":"Neurology"},{"key":"9558_CR54","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1440-1789.2009.01059.x","volume":"29","author":"Y Mitsuyama","year":"2009","unstructured":"Mitsuyama Y, Inoue T (2009) Clinical entity of frontotemporal dementia with motor neuron disease. Neuropathology 29:649\u2013654","journal-title":"Neuropathology"},{"key":"9558_CR55","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/gps.602","volume":"17","author":"R Moretti","year":"2002","unstructured":"Moretti R, Torre P, Antonello RM, Cazzato G, Bava A (2002) Effects of selegiline on fronto-temporal dementia: a neuropsychological evaluation. Int J Geriatr Psychiatry 17:391\u2013392","journal-title":"Int J Geriatr Psychiatry"},{"key":"9558_CR56","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000067021","volume":"49","author":"R Moretti","year":"2003","unstructured":"Moretti R, Torre P, Antonello RM, Cazzato G, Bava A (2003) Frontotemporal dementia: paroxetine as a possible treatment of behavior symptoms. A randomized, controlled, open 14-month study. Eur Neurol 49:13\u201319","journal-title":"Eur Neurol"},{"key":"9558_CR57","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2165\/00002512-200421140-00003","volume":"21","author":"R Moretti","year":"2004","unstructured":"Moretti R, Torre P, Antonello RM, Cattaruzza T, Cazzato G, Bava A (2004) Rivastigmine in frontotemporal dementia: an open-label study. Drugs Aging 21:931\u2013937","journal-title":"Drugs Aging"},{"key":"9558_CR58","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/sj.mp.4001483","volume":"9","author":"A Mudher","year":"2004","unstructured":"Mudher A, Shepherd D, Newman TA, Mildren P, Jukes JP, Squire A, Mears A, Drummond JA, Berg S, MacKay D, Asuni AA, Bhat R, Lovestone S (2004) GSK-3beta inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila. Mol Psychiatry 9:522\u2013530","journal-title":"Mol Psychiatry"},{"key":"9558_CR59","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1017\/S1462399409001136","volume":"11","author":"M Neumann","year":"2009","unstructured":"Neumann M, Tolnay M, Mackenzie IR (2009) The molecular basis of frontotemporal dementia. Expert Rev Mol Med 11:e23","journal-title":"Expert Rev Mol Med"},{"key":"9558_CR60","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1136\/jnnp.74.7.965","volume":"74","author":"T Odawara","year":"2003","unstructured":"Odawara T, Shiozaki K, Iseki E, Hino H, Kosaka K (2003) Alterations of muscarinic acetylcholine receptors in atypical Pick's disease without Pick bodies. J Neurol Neurosurg Psychiatry 74:965\u2013967","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9558_CR61","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neulet.2007.05.049","volume":"422","author":"A Padovani","year":"2007","unstructured":"Padovani A, Agosti C, Premi E, Bellelli G, Borroni B (2007) Extrapyramidal symptoms in frontotemporal dementia: prevalence and clinical correlations. Neurosci Lett 422:39\u201342","journal-title":"Neurosci Lett"},{"key":"9558_CR62","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ana.20828","volume":"59","author":"HS Panitch","year":"2006","unstructured":"Panitch HS, Thisted RA, Smith RA, Wynn DR, Wymer JP, Achiron A, Vollmer TL, Mandler RN, Dietrich DW, Fletcher M, Pope LE, Berg JE, Miller A (2006) Randomized, controlled trial of dextromethorphan\/quinidine for pseudobulbar affect in multiple sclerosis. Ann Neurol 59:780\u2013787","journal-title":"Ann Neurol"},{"key":"9558_CR63","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1212\/WNL.54.12.2277","volume":"54","author":"RJ Perry","year":"2000","unstructured":"Perry RJ, Hodges JR (2000) Differentiating frontal and temporal variant frontotemporal dementia from Alzheimer's disease. Neurology 54:2277\u20132284","journal-title":"Neurology"},{"issue":"Suppl 1","key":"9558_CR64","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000051219","volume":"10","author":"AW Procter","year":"1999","unstructured":"Procter AW, Qurne M, Francis PT (1999) Neurochemical features of frontotemporal dementia. Dement Geriatr Cogn Disord 10(Suppl 1):80\u201384","journal-title":"Dement Geriatr Cogn Disord"},{"key":"9558_CR65","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1136\/jnnp.2009.173260","volume":"80","author":"CI Prodan","year":"2009","unstructured":"Prodan CI, Monnot M, Ross ED (2009) Behavioural abnormalities associated with rapid deterioration of language functions in semantic dementia respond to sertraline. J Neurol Neurosurg Psychiatry 80:1416\u20131417","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9558_CR66","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/sj.npp.1300886","volume":"31","author":"S Rahman","year":"2006","unstructured":"Rahman S, Robbins TW, Hodges JR, Mehta MA, Nestor PJ, Clark L, Sahakian BJ (2006) Methylphenidate ('Ritalin') can ameliorate abnormal risk-taking behavior in the frontal variant of frontotemporal dementia. Neuropsychopharmacology 31:651\u2013658","journal-title":"Neuropsychopharmacology"},{"key":"9558_CR67","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1212\/WNL.58.11.1615","volume":"58","author":"E Ratnavalli","year":"2002","unstructured":"Ratnavalli E, Brayne C, Dawson K, Hodges JR (2002) The prevalence of frontotemporal dementia. Neurology 58:1615\u20131621","journal-title":"Neurology"},{"key":"9558_CR68","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/01.pra.0000271655.02093.49","volume":"13","author":"PR Recupero","year":"2007","unstructured":"Recupero PR, Rainey SE (2007) Managing risk when considering the use of atypical antipsychotics for elderly patients with dementia-related psychosis. J Psychiatr Pract 13:143\u2013152","journal-title":"J Psychiatr Pract"},{"key":"9558_CR69","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/ana.20301","volume":"56","author":"DA Reed","year":"2004","unstructured":"Reed DA, Johnson NA, Thompson C, Weintraub S, Mesulam MM (2004) A clinical trial of bromocriptine for treatment of primary progressive aphasia. Ann Neurol 56:750","journal-title":"Ann Neurol"},{"key":"9558_CR70","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1212\/WNL.58.10.1489","volume":"58","author":"JO Rinne","year":"2002","unstructured":"Rinne JO, Laine M, Kaasinen V, Norvasuo-Heila MK, Nagren K, Helenius H (2002) Striatal dopamine transporter and extrapyramidal symptoms in frontotemporal dementia. Neurology 58:1489\u20131493","journal-title":"Neurology"},{"key":"9558_CR71","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1086\/302256","volume":"64","author":"P Rizzu","year":"1999","unstructured":"Rizzu P, Van Swieten JC, Joosse M, Hasegawa M, Stevens M, Tibben A, Niermeijer MF, Hillebrand M, Ravid R, Oostra BA, Goedert M, van Duijn CM, Heutink P (1999) High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. Am J Hum Genet 64:414\u2013421","journal-title":"Am J Hum Genet"},{"key":"9558_CR72","first-page":"203","volume":"14","author":"A Robles","year":"1999","unstructured":"Robles A, Tourino R, Gude F, Noya M (1999) The tropicamide test in patients with dementia of Alzheimer type and frontotemporal dementia. Funct Neurol 14:203\u2013207","journal-title":"Funct Neurol"},{"key":"9558_CR73","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/ana.21056","volume":"61","author":"HJ Rosen","year":"2007","unstructured":"Rosen HJ, Cummings J (2007) A real reason for patients with pseudobulbar affect to smile. Ann Neurol 61:92\u201396","journal-title":"Ann Neurol"},{"key":"9558_CR74","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1093\/brain\/awg204","volume":"126","author":"SM Rosso","year":"2003","unstructured":"Rosso SM, Donker Kaat L, Baks T, Joosse M, de Koning I, Pijnenburg Y, de Jong D, Dooijes D, Kamphorst W, Ravid R, Niermeijer MF, Verheij F, Kremer HP, Scheltens P, van Duijn CM, Heutink P, van Swieten JC (2003) Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study. Brain 126:2016\u20132022","journal-title":"Brain"},{"key":"9558_CR75","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1136\/jnnp.2007.122853","volume":"79","author":"E Salmon","year":"2008","unstructured":"Salmon E, Perani D, Collette F, Feyers D, Kalbe E, Holthoff V, Sorbi S, Herholz K (2008) A comparison of unawareness in frontotemporal dementia and Alzheimer's disease. J Neurol Neurosurg Psychiatry 79:176\u2013179","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9558_CR76","doi-asserted-by":"crossref","first-page":"889","DOI":"10.4088\/JCP.v69n0602","volume":"69","author":"C Salzman","year":"2008","unstructured":"Salzman C, Jeste DV, Meyer RE, Cohen-Mansfield J, Cummings J, Grossberg GT, Jarvik L, Kraemer HC, Lebowitz BD, Maslow K, Pollock BG, Raskind M, Schultz SK, Wang P, Zito JM, Zubenko GS (2008) Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy. J Clin Psychiatry 69:889\u2013898","journal-title":"J Clin Psychiatry"},{"key":"9558_CR77","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1176\/appi.neuropsych.17.4.447","volume":"17","author":"R Schiffer","year":"2005","unstructured":"Schiffer R, Pope LE (2005) Review of pseudobulbar affect including a novel and potential therapy. J Neuropsychiatry Clin Neurosci 17:447\u2013454","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"5","key":"9558_CR78","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/jnnp.2010.212225","volume":"82","author":"H Seelaar","year":"2011","unstructured":"Seelaar H, Rohrer JD, Pijnenburg YA, Fox NC, van Swieten JC (2011) Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review. J Neurol Neurosurg Psychiatry 82(5):476\u2013486","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9558_CR79","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0197-4580(98)00086-4","volume":"19","author":"M Sjogren","year":"1998","unstructured":"Sjogren M, Minthon L, Passant U, Blennow K, Wallin A (1998) Decreased monoamine metabolites in frontotemporal dementia and Alzheimer's disease. Neurobiol Aging 19:379\u2013384","journal-title":"Neurobiol Aging"},{"key":"9558_CR80","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1001\/archneur.1991.00530200032014","volume":"48","author":"DL Sparks","year":"1991","unstructured":"Sparks DL, Markesbery WR (1991) Altered serotonergic and cholinergic synaptic markers in Pick's disease. Arch Neurol 48:796\u2013799","journal-title":"Arch Neurol"},{"key":"9558_CR81","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1001\/archneur.1991.00530190064017","volume":"48","author":"DL Sparks","year":"1991","unstructured":"Sparks DL, Woeltz VM, Markesbery WR (1991) Alterations in brain monoamine oxidase activity in aging, Alzheimer's disease, and Pick's disease. Arch Neurol 48:718\u2013721","journal-title":"Arch Neurol"},{"key":"9558_CR82","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/WAD.0b013e318047df5d","volume":"21","author":"MM Swanberg","year":"2007","unstructured":"Swanberg MM (2007) Memantine for behavioral disturbances in frontotemporal dementia: a case series. Alzheimer Dis Assoc Disord 21:164\u2013166","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"9558_CR83","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4088\/JCP.v58n0506","volume":"58","author":"JR Swartz","year":"1997","unstructured":"Swartz JR, Miller BL, Lesser IM, Darby AL (1997) Frontotemporal dementia: treatment response to serotonin selective reuptake inhibitors. J Clin Psychiatry 58:212\u2013216","journal-title":"J Clin Psychiatry"},{"key":"9558_CR84","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jalz.2007.06.001","volume":"4","author":"JQ Trojanowski","year":"2008","unstructured":"Trojanowski JQ, Duff K, Fillit H, Koroshetz W, Kuret J, Murphy D, Refolo L (2008) New directions for frontotemporal dementia drug discovery. Alzheimers Dement 4:89\u201393","journal-title":"Alzheimers Dement"},{"key":"9558_CR85","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1212\/WNL.33.11.1470","volume":"33","author":"GR Uhl","year":"1983","unstructured":"Uhl GR, Hilt DC, Hedreen JC, Whitehouse PJ, Price DL (1983) Pick's disease (lobar sclerosis): depletion of neurons in the nucleus basalis of Meynert. Neurology 33:1470\u20131473","journal-title":"Neurology"},{"key":"9558_CR86","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s11910-006-0051-6","volume":"6","author":"PS Wang","year":"2006","unstructured":"Wang PS, Brookhart MA, Setoguchi S, Patrick AR, Schneeweiss S (2006) Psychotropic medication use for behavioral symptoms of dementia. Curr Neurol Neurosci Rep 6:490\u2013495","journal-title":"Curr Neurol Neurosci Rep"},{"key":"9558_CR87","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/archneur.1991.00530140061018","volume":"48","author":"DR Weinberger","year":"1991","unstructured":"Weinberger DR, Gibson R, Coppola R, Jones DW, Molchan S, Sunderland T, Berman KF, Reba RC (1991) The distribution of cerebral muscarinic acetylcholine receptors in vivo in patients with dementia. A controlled study with 123IQNB and single photon emission computed tomography. Arch Neurol 48:169\u2013176","journal-title":"Arch Neurol"},{"key":"9558_CR88","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0022-510X(83)90200-9","volume":"62","author":"PL Wood","year":"1983","unstructured":"Wood PL, Etienne P, Lal S, Nair NP, Finlayson MH, Gauthier S, Palo J, Haltia M, Paetau A, Bird ED (1983) A post-mortem comparison of the cortical cholinergic system in Alzheimer's disease and Pick's disease. J Neurol Sci 62:211\u2013217","journal-title":"J Neurol Sci"},{"key":"9558_CR89","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s004010000293","volume":"101","author":"Y Yang","year":"2001","unstructured":"Yang Y, Schmitt HP (2001) Frontotemporal dementia: evidence for impairment of ascending serotoninergic but not noradrenergic innervation. Immunocytochemical and quantitative study using a graph method. Acta Neuropathol 101:256\u2013270","journal-title":"Acta Neuropathol"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-011-9558-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12031-011-9558-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-011-9558-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T22:23:18Z","timestamp":1592605398000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12031-011-9558-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,7]]},"references-count":89,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["9558"],"URL":"https:\/\/doi.org\/10.1007\/s12031-011-9558-7","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,7]]}}}